The estimated Net Worth of H. Lee Advisors, Llc Thomas... is at least 1.13 十億$ dollars as of 9 August 2018. Mr. Thomas owns over 6,000,000 units of Syneos Health Inc stock worth over 826,920,759$ and over the last 7 years he sold SYNH stock worth over 298,380,000$. In addition, he makes 90,000$ as Independent Director at Syneos Health Inc.
Thomas has made over 1 trades of the Syneos Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 6,000,000 units of SYNH stock worth 298,380,000$ on 9 August 2018.
The largest trade he's ever made was selling 6,000,000 units of Syneos Health Inc stock on 9 August 2018 worth over 298,380,000$. On average, Thomas trades about 2,000,000 units every 0 days since 2017. As of 9 August 2018 he still owns at least 19,239,664 units of Syneos Health Inc stock.
You can see the complete history of Mr. Thomas stock trades at the bottom of the page.
Thomas Allen serves as Independent Director of the Company. Mr. Allen has served as Managing Director, Advent International Ltd, an affiliate of Advent focusing on investments in the healthcare sector, since 2014. He has worked at Advent since 2004. Prior to joining Advent, he worked at Arthur Andersen and KPMG as part of the firms’ London private equity teams. Mr. Allen is currently a member of the board of Mediq, a provider of medical devices and care solutions, and a member of the board of Advent International Ltd. Mr. Allen is also on the board of directors of Zentiva Group, a leading European generics pharmaceutical company, where he serves on the Advisory Committee and Remuneration Committee, and GLOBAL MENSA S.L., the holding company of Vitaldent, a Spanish network of dental care clinics. Mr. Allen previously served on the board of Priory Group. Mr. Allen received his Bachelor of Arts degree in economics from the University of Manchester and is a qualified accountant.
As the Independent Director of Syneos Health Inc, the total compensation of Thomas Allen at Syneos Health Inc is 90,000$. There are 18 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of 7,646,360$.
Thomas Allen is 42, he's been the Independent Director of Syneos Health Inc since 2017. There are 21 older and no younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
Over the last 7 years, insiders at Syneos Health Inc have traded over 16,280,601,287$ worth of Syneos Health Inc stock and bought 17,946 units worth 873,496$ . The most active insiders traders include Todd M Abbrecht、John L. Maldonado、Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of 83,067,962$. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth 117,156$.
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Syneos Health Inc executives and other stock owners filed with the SEC include: